Fascioliasis Treatment Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 201

1. Fascioliasis Treatment Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2019 to 2026 Infections in humans and cattle due to food-borne parasites are widespread across the globe. Fascioliasis or liver fluke infection is prevalent amongst children, cattle and sheep in rural livestock rearing parts of the world like Peru, Vietnam, Bolivia, Egypt, Ecuador and Iran. The only way to intercept the transmission of Fascioliasis in endemic areas is through WHO (World Health Organisation) suggested anti- fascioliasis drugs like Triclabendazole. However, resistance to this WHO recommended drug and toxicity dangers associated with hexachloro-para-xylol, emetine, niclofolan, chloroquine, etc. has opened doors to the discovery of alternative medicines like Nitazoxanide. Furthermore, fascioliasis interfered with chronic conditions like ascending cholangitis are a challenge as they need appropriate antibacterial antibiotics. Thus in accordance with combat against the adverse consequences on public health and eventually socio-economic progress pharmaceutical companies are striving to provide a viable solution to neglected tropical disease. With the support from WHO and government bodies, global fascioliasis treatment market players can gain critical missing information about unsafe food that can help in drug innovation for Fascioliasis treatment. The research experts at FutureWise predicted a robust CAGR for the global fascioliasis treatment market during the forecast period 2019-2026. Request a Sample Report@ https://www.futurewiseresearch.com/request- sample.aspx?id=139&page=requestsample Global Fascioliasis Treatment Market, by Treatment Type • Standard Therapy • Supportive Therapy At present standard therapy holds the major global fascioliasis treatment market as significant dosage complications and temporary post-treatment side effects are issues better handled by standard therapy. The R&D efforts and investments for suitable standard drug discovery are estimated to augment standard therapy segment in the upcoming period. Also, WHO initiatives and support to provide free of cost drug in developing nations of endemic regions are to affect the growth of the market. Global Fascioliasis Treatment Market, by End-User • Hospitals • Clinics • Personalised cares

2. Global Fascioliasis Treatment Market, by Region • North America • Latin America • Europe • Asia Pacific • Rest of the World Due to stringent sanitation policies and high food quality standards, North America and Europe are to experience negligible CAGR in the near future. The high dependency on animal food sources, lack of awareness about hazards of raw vegetables and meat consumption and insufficient measures to curb the epidemic are factors that would triumph the robust CAGR in APAC and Latin America region. Purchase a Copy & Ask For Discount: https://www.futurewiseresearch.com/request- sample.aspx?id=139&page=askfordiscount Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Key Takeaways • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the global fascioliasis treatment market on the basis of treatment type, distribution channel, and region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions • Profiling of companies to evaluate their market shares, strategies, financials and core competencies Table of Contents 1.Introduction

3. 1.Scope and Objective 2.Assumptions and Acronyms 3.Forecast Factors 4.Research Methodology 2.Executive Summary 1.Industry Cluster Analysis 2.Competition Matrix 3.Strategies Recommendations 3.Market Definition 1.Report Scope (Inclusions & Exclusions) 2.Market Segmentation 4.Global Fascioliasis Treatment Market Overview 1.Global Fascioliasis Treatment Market Revenue (USD Mn) 5.Key Inclusions 1.Porter’s Five Force analysis 2.Market Dynamics 3.Industry Trends 4.Regulatory Guidelines 5.Opportunities in Fascioliasis Treatment 6.Competition Dynamics 1.Company Share Analysis (2018) 2.Top 10 Product Pricing by Region 7.Global Fascioliasis Treatment Market Revenue (USD Mn), 2018-2026 by Treatment Type 1.Key Market Findings 2.Long Term ROI Segments 3.Revenue Opportunity Influencing Factors 4.Market Revenue (USD Mn) Assessment and Forecast by Treatment Type, 2018-2026 1.Standard Therapy 2.Supportive Therapy 8.Global Fascioliasis Treatment Market Revenue (USD Mn), 2018-2026 by End User 1.Key Market Findings 2.Long Term ROI Segments 1.Revenue Opportunity Influencing Factors 3.Market Revenue (USD Mn) Assessment and Forecast by End User, 2018-2026 1.Hospitals 2.Clinics 3.Personalised care 9.Global Fascioliasis Treatment Market Revenue (USD Mn), 2018-2026 by Region

4. 1.Key Market Findings 2.Long Term ROI Segments 3.Revenue Opportunity Influencing Factors 4.Market Revenue (USD Mn) Assessment and Forecast by Region,2026 1.North America 2.Latin America 3.Europe 4.Asia Pacific 5.Rest of world 10.North America Fascioliasis Treatment Market Revenue (US$ Mn), 2018-2026 1.Key Market Findings 2.Long Term ROI Segments 3.Revenue Opportunity Influencing Factors 4.Market Revenue (USD Mn) Assessment and Forecast by Country, 2018- 2026 5.US 6.Canada 7.Market Revenue (USD Mn) Assessment and Forecast by Treatment Type, 2018-2026 8.Standard Therapy 9.Supportive Therapy 10.Market Revenue (USD Mn) Assessment and Forecast by End User, 2018-2026 11.Hospitals 12.Clinics 13.Personalised care 11.Latin America Fascioliasis Treatment Market Revenue (US$ Mn), 2018-2026 1.Key Market Findings 2.Long Term ROI Segments 3.Revenue Opportunity Influencing Factors 4.Market Revenue (USD Mn) Assessment and Forecast by Country, 2018- 2026 5.Brazil 6.Mexico 7.Argentina 8.Rest of Latin America 9.Market Revenue (USD Mn) Assessment and Forecast by Treatment Type, 2018-2026 10.Standard Therapy 11.Supportive Therapy 12.Market Revenue (USD Mn) Assessment and Forecast by End User, 2018-2026 13.Hospitals

5. 14.Clinics 15.Personalised care 12.Europe America Fascioliasis Treatment Market Revenue (US$ Mn), 2018- 2026 1.Key Market Findings 2.Long Term ROI Segments 3.Revenue Opportunity Influencing Factors 4.Market Revenue (USD Mn) Assessment and Forecast by Country, 2018- 2026 5.Germany 6.France 7.Spain 8.UK 9.Russia 10.Poland 11.Rest of Europe 12.Market Revenue (USD Mn) Assessment and Forecast by Treatment Type, 2018-2026 13.Standard Therapy 14.Supportive Therapy 15.Market Revenue (USD Mn) Assessment and Forecast by End User, 2018-2026 16.Hospitals 17.Clinics 18.Personalised care 13.Asia Pacific America Fascioliasis Treatment Market Revenue (US$ Mn), 2018- 2026 1.Key Market Findings 2.Long Term ROI Segments 3.Revenue Opportunity Influencing Factors 4.Market Revenue (USD Mn) Assessment and Forecast by Country, 2018- 2026 5.Emerging Asia 1.China 2.India 3.ASEAN-5 4.Rest of Emerging Asia 14.Japan 15.Market Revenue (USD Mn) Assessment and Forecast by Treatment Type, 2018-2026 16.Standard Therapy 17.Supportive Therapy 18.Market Revenue (USD Mn) Assessment and Forecast by End User, 2018-2026

6. 19.Hospitals 20.Clinics 21.Personalised care 22.Rest of World America Fascioliasis Treatment Market Revenue (US$ Mn), 2018-2026 1.Key Market Findings 2.Long Term ROI Segments 3.Revenue Opportunity Influencing Factors 4.Market Revenue (USD Mn) Assessment and Forecast by Country, 2018- 2026 5.Middle East 6.South Africa 7.North Africa 8.Rest of World 9.Market Revenue (USD Mn) Assessment and Forecast by Treatment Type, 2018-2026 10.Standard Therapy 11.Supportive Therapy 12.Market Revenue (USD Mn) Assessment and Forecast by End User, 2018-2026 13.Hospitals 14.Clinics 15.Personalised care 23.Company Profiles 1.Competition Landscape 2.Global Company Share (USD Mn) Overview, 2018 3.Company Profiles 4.Merck Limited 1.Corporate Overview 2.Financial Performance 3.Peer Comparison & 3C marketing equation 4.Company Strategy & Channel Management 24.Novartis Animal Health GmbH 1.Corporate Overview 2.Financial Performance 3.Peer Comparison & 3C marketing equation 4.Company Strategy & Channel Management 25.Norbrook Laboratories Ltd 1.Corporate Overview 2.Financial Performance 3.Peer Comparison & 3C marketing equation 4.Company Strategy & Channel Management 26.Janssen Pharmaceutica N.V.

7. 1.Corporate Overview 2.Financial Performance 3.Peer Comparison & 3C marketing equation 4.Company Strategy & Channel Management 27.Pfizer Inc. 1.Corporate Overview 2.Financial Performance 3.Peer Comparison & 3C marketing equation 4.Company Strategy & Channel Management 28.Research Sources & Primary Verbatim Inquire further details about this report at: sales@futurewiseresearch.com About FutureWise Research: We specialise in high-growth niche markets, assuring flexibility, agility and customised solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry – a position secured for far more than the near future. Contact Us: Company Name: FutureWise Research Contact Person: Vinay Thaploo Email: sales@futurewiseresearch.com Phone: +44 141 628 9353 / +1 970 279 4295 City: Leeds Country: United Kingdom Website: www.futurewiseresearch.com